Tops & Flops Stocks
Security | Change (%) | 1w | 1m ▼ | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Enwave Corporation | -4.240% | -10.000% | -20.313% | -42.045% | -37.805% | -83.792% | -89.961% |
Nevro Corp. | 3.190% | -6.731% | -20.492% | -60.887% | -51.010% | -91.983% | -79.630% |
X4 Pharmaceuticals, Inc. | 0.260% | -8.714% | -21.952% | -27.444% | 25.577% | - | - |
Enanta Pharmaceuticals Inc. | -2.520% | -16.547% | -23.179% | -49.565% | 31.818% | -72.115% | -85.078% |
Accuray Inc. | -1.990% | 13.889% | -23.364% | -49.693% | -37.879% | -56.614% | - |
MicroVision Inc | 3.190% | -24.356% | -25.239% | -51.526% | -55.336% | -89.773% | 44.430% |
Medigene AG | 4.410% | -5.145% | -28.398% | -11.145% | -7.233% | -62.611% | -83.095% |
Atara Biotherapeutics Inc. | -1.720% | -21.831% | -28.555% | -75.177% | -4.385% | -95.527% | - |
Active Biotech AB | -29.400% | -3.288% | -29.400% | -22.418% | 18.060% | -69.251% | -86.423% |
Owens & Minor Inc. | 1.190% | -24.779% | -29.752% | 0.000% | -2.857% | -39.068% | - |
Ocular Therapeutix Inc. | -1.060% | -8.170% | -30.016% | -8.042% | 25.357% | -59.538% | 62.396% |
Fate Therapeutics Inc. | 5.480% | 0.317% | -30.122% | -17.274% | 6.665% | -93.672% | - |
Viracta Therapeutics Inc. | -3.360% | -3.356% | -32.075% | -31.429% | 45.749% | -90.414% | -98.255% |
Strata Skin Sciences Inc. | -2.560% | -6.173% | -37.190% | -66.957% | -37.705% | -74.876% | -86.561% |
Brainstorm Cell | 19.620% | -1.286% | -37.635% | -86.398% | 48.922% | -87.661% | - |
Pacific Biosciences of California Inc. | 10.630% | -2.808% | -44.797% | -85.327% | -82.405% | -91.321% | -74.618% |
Abeona Therapeutics Inc. | -5.770% | -8.879% | -45.070% | 41.509% | -17.197% | -86.689% | - |
EyePoint Pharmaceuticals Inc. | -1.920% | -38.816% | -47.446% | 105.780% | -47.593% | 53.630% | - |
Bone Therapeutics S.A. | -5.080% | -11.111% | -65.432% | -95.254% | -93.000% | -99.754% | -99.846% |
MacroGenics Inc. | 32.600% | -78.352% | -81.370% | -53.424% | -65.844% | -87.160% | - |
Glycomimetics Inc. | 2.040% | -85.639% | -89.087% | -86.236% | -89.159% | -86.236% | - |